Endomicroscopy will track injected mesenchymal stem cells in rat colitis models

Ming Li, Yi Xin Zhang, Zhen Zhang, Xiao Yan Zhou, Xiu Li Zuo, Yingzi Cong, Yan Qing Li

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Mesenchymal stem cells (MSCs) have demonstrated significant potentials for the treatment of inflammatory bowel disease. Clinical feasible methods to individually document the MSC recruitment to intestinal mucosa is lacking. Here, we proposed that endomicroscopy could noninvasively track MSCs in vivo at cellular resolution. Method: Isolated Sprague Dawley rat MSC was characterized, fluorescently labeled, and imaged ex vivo using an endomicroscope. Then enhanced green fluorescent protein (eGFP)-labeled MSC was tracked in vivo, and acquired images were compared with immunofluorescence, immunohistology, and fluorescent in situ hybridization results. Results: Endomicroscopy visualized clearly the eGFP-labeled or carboxyfluorescein succinimidyl ester-stained MSC ex vivo. Endomicroscopy using the FIVE1 system could track eGFP-labeled MSC with distinct in vivo features. Immunofluorescence, immunohistochemistry, and fluorescent in situ hybridization confirmed the presence of eGFP-positive cells. In vivo endomicroscopy could quantify the transplanted MSCs that homed to colonic mucosa of the recipient rat in multiple models, including the rat-to-rat allograft, human-to-rat xenograft, hypoxia-induced MSC, and busulfan immunosuppressed recipient rat models. After hypoxia induction, there was a trend of enhanced rat MSC homing to the inflamed mucosa as visualized by endomicroscopy (114.1 in hypoxia group versus 34.3 in other 3 groups combined, t 2.14, P 0.0644). Conclusions: Endomicroscopy is a novel and promising tool to track transplanted MSCs to the colonic mucosa. This clinical available noninvasive cellular tracking method may provide new insight to individualize each recipient's regimen in the future.

Original languageEnglish (US)
Pages (from-to)2068-2077
Number of pages10
JournalInflammatory Bowel Diseases
Volume21
Issue number9
DOIs
StatePublished - Jun 12 2015

Fingerprint

Colitis
Mesenchymal Stromal Cells
Mucous Membrane
Fluorescence In Situ Hybridization
Fluorescent Antibody Technique
Busulfan
Intestinal Mucosa
Inflammatory Bowel Diseases
Heterografts
Allografts
Sprague Dawley Rats
Esters
Immunohistochemistry
enhanced green fluorescent protein

Keywords

  • confocal laser endomicroscope
  • inflammatory bowel disease
  • mesenchymal stem cells

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Endomicroscopy will track injected mesenchymal stem cells in rat colitis models. / Li, Ming; Zhang, Yi Xin; Zhang, Zhen; Zhou, Xiao Yan; Zuo, Xiu Li; Cong, Yingzi; Li, Yan Qing.

In: Inflammatory Bowel Diseases, Vol. 21, No. 9, 12.06.2015, p. 2068-2077.

Research output: Contribution to journalArticle

Li, Ming ; Zhang, Yi Xin ; Zhang, Zhen ; Zhou, Xiao Yan ; Zuo, Xiu Li ; Cong, Yingzi ; Li, Yan Qing. / Endomicroscopy will track injected mesenchymal stem cells in rat colitis models. In: Inflammatory Bowel Diseases. 2015 ; Vol. 21, No. 9. pp. 2068-2077.
@article{0fc0c1e1a01f4c4188fb8dd9c30fa6e4,
title = "Endomicroscopy will track injected mesenchymal stem cells in rat colitis models",
abstract = "Background: Mesenchymal stem cells (MSCs) have demonstrated significant potentials for the treatment of inflammatory bowel disease. Clinical feasible methods to individually document the MSC recruitment to intestinal mucosa is lacking. Here, we proposed that endomicroscopy could noninvasively track MSCs in vivo at cellular resolution. Method: Isolated Sprague Dawley rat MSC was characterized, fluorescently labeled, and imaged ex vivo using an endomicroscope. Then enhanced green fluorescent protein (eGFP)-labeled MSC was tracked in vivo, and acquired images were compared with immunofluorescence, immunohistology, and fluorescent in situ hybridization results. Results: Endomicroscopy visualized clearly the eGFP-labeled or carboxyfluorescein succinimidyl ester-stained MSC ex vivo. Endomicroscopy using the FIVE1 system could track eGFP-labeled MSC with distinct in vivo features. Immunofluorescence, immunohistochemistry, and fluorescent in situ hybridization confirmed the presence of eGFP-positive cells. In vivo endomicroscopy could quantify the transplanted MSCs that homed to colonic mucosa of the recipient rat in multiple models, including the rat-to-rat allograft, human-to-rat xenograft, hypoxia-induced MSC, and busulfan immunosuppressed recipient rat models. After hypoxia induction, there was a trend of enhanced rat MSC homing to the inflamed mucosa as visualized by endomicroscopy (114.1 in hypoxia group versus 34.3 in other 3 groups combined, t 2.14, P 0.0644). Conclusions: Endomicroscopy is a novel and promising tool to track transplanted MSCs to the colonic mucosa. This clinical available noninvasive cellular tracking method may provide new insight to individualize each recipient's regimen in the future.",
keywords = "confocal laser endomicroscope, inflammatory bowel disease, mesenchymal stem cells",
author = "Ming Li and Zhang, {Yi Xin} and Zhen Zhang and Zhou, {Xiao Yan} and Zuo, {Xiu Li} and Yingzi Cong and Li, {Yan Qing}",
year = "2015",
month = "6",
day = "12",
doi = "10.1097/MIB.0000000000000458",
language = "English (US)",
volume = "21",
pages = "2068--2077",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Endomicroscopy will track injected mesenchymal stem cells in rat colitis models

AU - Li, Ming

AU - Zhang, Yi Xin

AU - Zhang, Zhen

AU - Zhou, Xiao Yan

AU - Zuo, Xiu Li

AU - Cong, Yingzi

AU - Li, Yan Qing

PY - 2015/6/12

Y1 - 2015/6/12

N2 - Background: Mesenchymal stem cells (MSCs) have demonstrated significant potentials for the treatment of inflammatory bowel disease. Clinical feasible methods to individually document the MSC recruitment to intestinal mucosa is lacking. Here, we proposed that endomicroscopy could noninvasively track MSCs in vivo at cellular resolution. Method: Isolated Sprague Dawley rat MSC was characterized, fluorescently labeled, and imaged ex vivo using an endomicroscope. Then enhanced green fluorescent protein (eGFP)-labeled MSC was tracked in vivo, and acquired images were compared with immunofluorescence, immunohistology, and fluorescent in situ hybridization results. Results: Endomicroscopy visualized clearly the eGFP-labeled or carboxyfluorescein succinimidyl ester-stained MSC ex vivo. Endomicroscopy using the FIVE1 system could track eGFP-labeled MSC with distinct in vivo features. Immunofluorescence, immunohistochemistry, and fluorescent in situ hybridization confirmed the presence of eGFP-positive cells. In vivo endomicroscopy could quantify the transplanted MSCs that homed to colonic mucosa of the recipient rat in multiple models, including the rat-to-rat allograft, human-to-rat xenograft, hypoxia-induced MSC, and busulfan immunosuppressed recipient rat models. After hypoxia induction, there was a trend of enhanced rat MSC homing to the inflamed mucosa as visualized by endomicroscopy (114.1 in hypoxia group versus 34.3 in other 3 groups combined, t 2.14, P 0.0644). Conclusions: Endomicroscopy is a novel and promising tool to track transplanted MSCs to the colonic mucosa. This clinical available noninvasive cellular tracking method may provide new insight to individualize each recipient's regimen in the future.

AB - Background: Mesenchymal stem cells (MSCs) have demonstrated significant potentials for the treatment of inflammatory bowel disease. Clinical feasible methods to individually document the MSC recruitment to intestinal mucosa is lacking. Here, we proposed that endomicroscopy could noninvasively track MSCs in vivo at cellular resolution. Method: Isolated Sprague Dawley rat MSC was characterized, fluorescently labeled, and imaged ex vivo using an endomicroscope. Then enhanced green fluorescent protein (eGFP)-labeled MSC was tracked in vivo, and acquired images were compared with immunofluorescence, immunohistology, and fluorescent in situ hybridization results. Results: Endomicroscopy visualized clearly the eGFP-labeled or carboxyfluorescein succinimidyl ester-stained MSC ex vivo. Endomicroscopy using the FIVE1 system could track eGFP-labeled MSC with distinct in vivo features. Immunofluorescence, immunohistochemistry, and fluorescent in situ hybridization confirmed the presence of eGFP-positive cells. In vivo endomicroscopy could quantify the transplanted MSCs that homed to colonic mucosa of the recipient rat in multiple models, including the rat-to-rat allograft, human-to-rat xenograft, hypoxia-induced MSC, and busulfan immunosuppressed recipient rat models. After hypoxia induction, there was a trend of enhanced rat MSC homing to the inflamed mucosa as visualized by endomicroscopy (114.1 in hypoxia group versus 34.3 in other 3 groups combined, t 2.14, P 0.0644). Conclusions: Endomicroscopy is a novel and promising tool to track transplanted MSCs to the colonic mucosa. This clinical available noninvasive cellular tracking method may provide new insight to individualize each recipient's regimen in the future.

KW - confocal laser endomicroscope

KW - inflammatory bowel disease

KW - mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=84940903659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940903659&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000000458

DO - 10.1097/MIB.0000000000000458

M3 - Article

VL - 21

SP - 2068

EP - 2077

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 9

ER -